Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TXMD |
---|---|---|
09:32 ET | 456 | 2.26 |
09:43 ET | 476 | 2.3 |
09:45 ET | 508 | 2.2555 |
09:54 ET | 131 | 2.2915 |
10:17 ET | 206 | 2.2957 |
10:24 ET | 100 | 2.25 |
10:35 ET | 100 | 2.29 |
10:48 ET | 200 | 2.275 |
10:51 ET | 200 | 2.3 |
11:11 ET | 167 | 2.2603 |
12:16 ET | 217 | 2.3 |
12:21 ET | 222 | 2.2701 |
12:43 ET | 400 | 2.295 |
12:50 ET | 200 | 2.3 |
12:52 ET | 100 | 2.31 |
12:59 ET | 214 | 2.31 |
01:24 ET | 508 | 2.27 |
01:55 ET | 281 | 2.2601 |
02:36 ET | 500 | 2.26 |
03:05 ET | 100 | 2.28 |
03:16 ET | 100 | 2.28 |
03:57 ET | 100 | 2.3 |
03:59 ET | 353 | 2.29 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TherapeuticsMD Inc | 24.2M | -0.6x | --- |
Lotus Pharmaceuticals Inc | 13.5M | 0.1x | +42.39% |
Cumberland Pharmaceuticals Inc | 23.8M | -3.8x | --- |
Aoxing Pharmaceutical Company Inc | 1.8M | -0.3x | --- |
Tibet Pharmaceuticals Inc | 10.0 | 0.0x | --- |
Aida Pharmaceuticals Inc | 5.4K | 0.0x | --- |
TherapeuticsMD, Inc. is a healthcare company. The Company is focused on developing and commercializing products exclusively for women. It is engaged in conducting business by out-licensing its products and collecting royalties, after granting a license to commercialize the Company's IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands in the United States and its possessions and territories and assigning the Company’s exclusive license to commercialize ANNOVERA in the United States and its possessions and territories to Mayne Pharma. ANNOVERA is a one-year (13 cycles) ring-shaped contraceptive vaginal system (CVS)). ANNOVERA, which is made with a silicone elastomer, contains segesterone acetate, a 19-nor progesterone derivative also known as Nestorone (SA) and ethinyl estradiol (EE). Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $24.2M |
---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 10.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.03 |
EPS | $-4.11 |
Book Value | $3.70 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 12.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | 3,078.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.